A narrative review of mechanistic evidence from in vitro and preclinical studies, lacking clinical trials, efficacy data, or validated targets in humans; raises questions for investigation rather than answering them.
This is a narrative review summarizing existing evidence and proposing intrapancreatic fat as a biologically plausible mediator of pancreatic cancer risk, rather than presenting primary empirical evidence or a definitive causal relationship.
This is an exploratory genomic analysis of publicly available data identifying potential molecular subsets of pancreatic NETs, raising questions about prognostic stratification but lacking validation, clinical outcomes, or therapeutic testing.
This is a narrative review synthesizing existing knowledge on KLH structure and immunological mechanisms; it raises questions about therapeutic potential but does not present original clinical trial data or definitive evidence of efficacy.
A narrative review proposing mechanistic hypotheses about supplement-based NK cell enhancement in pancreatic cancer, without reporting primary experimental data or clinical trial results.
This is a narrative review synthesizing preclinical mechanisms and observational human data on MDSC biology in cardiometabolic disease, raising questions about dualistic roles rather than reporting new empirical results.
In vitro mechanistic study using cell line models to explore transcriptional changes associated with cisplatin resistance; raises questions about EMT involvement rather than answering clinical questions with human data.